Science Explorer Back to mapMap
Discussion
Topic · Biomedical Engineering

Nanoplatforms for cancer theranostics

Nanoplatforms for cancer theranostics is a research topic within Biomedical Engineering. Science Explorer counts 50k research works in it since 1952. 9.7% of them reached the world's top 10% most cited for their field and year.

This cluster of papers explores the use of nanotechnology, reactive oxygen species, and advanced imaging techniques for targeted cancer therapy and diagnosis. It covers a wide range of topics including photothermal therapy, fluorescence imaging, nanoparticle-based drug delivery, and the development of theranostic agents for combined imaging and therapy. The research also delves into the potential of immunotherapy and the use of biomimetic nanoparticles for enhanced cancer treatment.

  • Nanoparticles
  • Photothermal Therapy
  • Reactive Oxygen Species
  • Fluorescence Imaging
  • Photodynamic Therapy
  • Near-Infrared
  • Tumor Targeting
  • Immunotherapy
  • Biomimetic Nanoparticles
  • Theranostic Agents
Research works
50k
fractional, since 1952
In the world top 10%
4.8k
per year above
Top-10% rate
9.7%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+53%
the tick is no change
Largest producer
China
67% of the 10 largest, 2022-now
Nanoplatforms for cancer theranostics

Which countries lead Nanoplatforms for cancer theranostics research?

By volume, China and the United States publish the most (12k and 2.1k works in 2022-now).

By volume, 2022-now

  1. 1 China 12k works
  2. 2 United States 2.1k works
  3. 3 India 1.3k works
  4. 4 South Korea 589 works
  5. 5 Iran 439 works
  6. 6 Japan 388 works
  7. 7 ?? 304 works
  8. 8 Italy 303 works
  9. 9 Russia 300 works
  10. 10 Germany 300 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 67.3%United States: 11.3%India: 6.9%South Korea: 3.2%6 others listed: 11.2%67%largest
China12k · 67.3%United States2,060 · 11.3%India1,260 · 6.9%South Korea589 · 3.2%6 others listed2,034 · 11.2%

Shares of the rows listed above, not of the whole node.

Which institutions lead Nanoplatforms for cancer theranostics research?

By volume in 2022-now, Chinese Academy of Sciences publishes the most Nanoplatforms for cancer theranostics research, followed by Sichuan University and Shanghai Jiao Tong University.

By volume, 2022-now

  1. 1 Chinese Academy of SciencesChina 601 works
  2. 2 Sichuan UniversityChina 311 works
  3. 3 Shanghai Jiao Tong UniversityChina 285 works
  4. 4 Sun Yat-sen UniversityChina 216 works
  5. 5 Zhejiang UniversityChina 194 works
  6. 6 Soochow UniversityChina 172 works
  7. 7 Fudan UniversityChina 168 works
  8. 8 Jilin UniversityChina 155 works
  9. 9 Southern Medical UniversityChina 152 works
  10. 10 Wuhan UniversityChina 147 works

Who are the leading researchers in Nanoplatforms for cancer theranostics?

The most-cited researchers publishing on Nanoplatforms for cancer theranostics include Zhong Lin Wang, Michaël Grätzel and Guido Kroemer.

  1. 1 Zhong Lin Wang United States 491k citations
  2. 2 Michaël Grätzel Switzerland 458k citations
  3. 3 Guido Kroemer France 386k citations
  4. 4 Bert Vogelstein United States 373k citations
  5. 5 Jost Bruno Jonas Germany 350k citations
  6. 6 Jun Wang China 340k citations
  7. 7 Yury G. Gogotsi United States 313k citations
  8. 8 Róbert Langer United States 303k citations
  9. 9 Wei Huang China 267k citations
  10. 10 Gordon Brent Mills United States 265k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Nanoplatforms for cancer theranostics?

The most cited paper in Nanoplatforms for cancer theranostics is "Photodynamic therapy for cancer" (Dennis E. J. G. J. Dolmans, Dai Fukumura, Rakesh K. Jain, 2003), with 6,780 citations. Next come "Cancer nanomedicine: progress, challenges and opportunities" (5,834) and "Cancer Cell Imaging and Photothermal Therapy in the Near-Infrared Region by Using Gold Nanorods" (5,431).

Most cited papers
#PaperReleasedCitations
1 Photodynamic therapy for cancer Dennis E. J. G. J. Dolmans, Dai Fukumura, Rakesh K. Jain · Nature reviews. Cancer Review May 2003 6,780
2 Cancer nanomedicine: progress, challenges and opportunities Jinjun Shi, Philip W. Kantoff, Richard F. Wooster et al. · Nature reviews. Cancer ReviewOpen access 11 Nov 2016 5,834
3 Cancer Cell Imaging and Photothermal Therapy in the Near-Infrared Region by Using Gold Nanorods Xiaohua Huang, Ivan H. El‐Sayed, Wei Ping Qian et al. · Journal of the American Chemical Society 21 Jan 2006 5,431
4 Photodynamic therapy of cancer: An update Patrizia Agostinis, Kristian Berg, Keith A. Cengel et al. · CA A Cancer Journal for Clinicians Open access 26 May 2011 5,169
5 In vivo cancer targeting and imaging with semiconductor quantum dots Xiaohu Gao, Yuanyuan Cui, Richard M. Levenson et al. · Nature Biotechnology 18 Jul 2004 4,765
All 100 most cited papers, with filters and sorting

Where is Nanoplatforms for cancer theranostics research done?

The largest centres of Nanoplatforms for cancer theranostics research in 2022-now are Beijing (China), Shanghai (China), Guangzhou (China) and Nanjing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Tianjin, Nanjing and Changchun.

Largest cities, 2022-now

  1. 1 BeijingChina 1.3k works
  2. 2 ShanghaiChina 1.1k works
  3. 3 GuangzhouChina 737 works
  4. 4 NanjingChina 686 works
  5. 5 WuhanChina 514 works
  6. 6 HangzhouChina 455 works
  7. 7 ChengduChina 450 works
  8. 8 ShenzhenChina 345 works
  9. 9 Xi'anChina 342 works
  10. 10 TianjinChina 335 works

Where it is the local speciality

  1. Tianjin22.1 works33×
  2. Nanjing32.2 works14×
  3. Changchun22.1 works12×
  4. Chengdu38.3 works11×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Nanoplatforms for cancer theranostics than the world average.

See Nanoplatforms for cancer theranostics on the map

Where is the best place to study Nanoplatforms for cancer theranostics?

Among universities, judged by research, Chinese University of Hong Kong, Shenzhen, Soochow University and Sichuan University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 18.67%fractional works in this field (log) →share of work in the world top 10% →Nanyang Technologica…Chinese University o…Soochow UniversitySichuan University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Chinese University of Hong Kong, ShenzhenChina 71.924.4%14.7×50 +769.3%
2Soochow UniversityChina 70.815.4%9.6×172 +47.1%
3Sichuan UniversityChina 69.815.2%7.5×311 +97.3%
4Nanyang Technological UniversitySingapore 67.430.7%3.1×46 -34.6%
5Shanghai Jiao Tong UniversityChina 67.013.9%5.3×285 +76.0%
6Wuhan UniversityChina 65.516.7%5.6×147 +33.7%
7Fudan UniversityChina 64.414.1%5.8×168 +60.8%
8Shenzhen UniversityChina 64.317.7%6.4×87 +66.3%
9University of MacauChina 63.416.8%7.1×42 +67.3%
10National University of SingaporeSingapore 63.021.8%2.7×60 +4.1%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Nanoplatforms for cancer theranostics, country by country

Is Nanoplatforms for cancer theranostics research growing?

Output in 2022-2025 was 53% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Nanoplatforms for cancer theranostics.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Nanoplatforms for cancer theranostics as a percentage of every work published that year, 0.086% in 2024.

still counting0.050%0.10%Nanoplatforms for cancer theranostics0.093% in 202519801990200020102020

Fractional works of Nanoplatforms for cancer theranostics over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Nanoplatforms for cancer theranostics9.6% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Nanoplatforms for cancer theranostics. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.